Methodology to standardize heterogeneous statistical data presentations for combining time-to-event oncologic outcomes | PLOS ONE
Progression Free Survival
Survival Analysis Basics - Easy Guides - Wiki - STHDA
xmlinkhub
Survival Analysis Basics - Easy Guides - Wiki - STHDA
312: Survival After Disease Progression of Patients with Locally Advanced Bladder Cancer Previously Treated with Radical Cystect
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients | Aging
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Disease-free Survival and Invasive-Disease-free Survival in the... | Download Scientific Diagram
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
JCM | Free Full-Text | The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer
ASCO GU 2023: FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy and 6 Months of GnRH Agonist with or Without Abiraterone Acetate/prednisone and Apalutamide Post-Radical Prostatectomy
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics | PLOS ONE
Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study - Xin Wu, Binglu Li, Chaoji Zheng, 2022
Progression Free Survival
Value-Based Calculators in Cancer: Current State and Challenges | JCO Oncology Practice
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
Measures of Disease Frequency
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Kaplan–Meier plots for disease-free survival (DFS) (A) and overall... | Download Scientific Diagram
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms
View Image
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma | Journal for ImmunoTherapy of Cancer | Full Text
Disease-free survival curve (Kaplan Meier) associated with clusterin... | Download Scientific Diagram
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms
